We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shire | LSE:SHP | London | Ordinary Share | JE00B2QKY057 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4,690.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
15/1/2006 08:35 | Markth My Igindex account has just been opened. I won't use it until I completely understand the principles. I have noticed that you seem to close out daily. Do you need to do this? IG seem to indicate that you close your position at the end of the day and that if you want to continue you can reopen with a reduced spread. Am I reading this right? Sorry about your losses last week but it seems (although in hindsight) that if your position remained open you would have gained at some point. Is timing crucial or can you hang on? | rfv | |
13/1/2006 15:25 | added to my long | markth | |
13/1/2006 14:38 | A deal will not be good as it would then be anti-competitive | inv | |
13/1/2006 11:59 | You were saying, RFV? | markth | |
13/1/2006 09:19 | Market Report: Shire surges on hopes of end to patent disputes Hopes that Shire Pharmaceuticals is close to settling a number of patent disputes with rival drug makers sent its shares to the top of the FTSE 100 gainers list. Shire soared 7 per cent, or 55.5p, to 850.5p yesterday, on talk the group will soon settle its disagreements with generic producers trying to challenge patents on its key hyperactivity drug Adderall XR. It seems the speculation was prompted by comments by Matthew Emmens, the pharma group's chief executive, at an investor conference in the US this week. Adderall is important for the group - it accounts for nearly half of its total sales - so it is no surprise that rumours about its future had such an impact on the company's shares. Traders hope that a settlement will greatly extend Adderall's shelf life. Deutsche Bank also seemed to hint that a deal is on the way. The broker said: "It is certainly not unreasonable to assume there is an increasing likelihood that Shire and one or more of its generic challengers (most notably Barr Laboratories and Impax) will settle." | zho | |
12/1/2006 15:44 | Unless by fluke you time this perfectly I wouldn't bother shorting tomorrow. There's more to come especially if Impax follows suit. | rfv | |
12/1/2006 15:08 | Thar she blows, wheeeeeee! | markth | |
12/1/2006 14:03 | Resistance is futile, lol. Looks set to re-test this morning's high once WS opens. | markth | |
12/1/2006 13:19 | No way aclark. Those comments were made after I had traded in and out already. I only posted cos there were some misleading comments from yesterday and this morning by another poster. I shorted 8:29am at 844.7p and covered 9:08am at 839.3p. You can see the time of the posting for yourself at 10:29am. Incidentally I am not stupid enough to try to influence the price movement of a share and certainly not something the size of Shire. Its futile. | prokartace | |
12/1/2006 12:53 | Prokartace - now i see why you made your comments in 321 !!! | aclark9201 | |
12/1/2006 11:53 | OK I'm out. | markth | |
12/1/2006 11:13 | Ditto. Well 5.5 pionts.... | prokartace | |
12/1/2006 10:41 | That'll do me nicely, managed to scalp 6 points. Should I wait... | markth | |
12/1/2006 10:27 | From Sharecast's market report this morning: Shire led the risers after Deutsche Bank lifted its target price on the shares and talked of a possible settlement between the company and Barr over a generic copy of Shire's hyperactivity treatment Adderall XR. | zho | |
12/1/2006 10:26 | This has absolutely no connection with an offer for the company. Its an agreement which allows Shire to maintain its patent on Adderall for longer. They will however eventually lose it. On the back of this Deutsche Bank have upgraded their target share price for Shire. | prokartace | |
12/1/2006 10:18 | There's supposed to be some deal with Barr over Adderall XR | aclark9201 | |
12/1/2006 09:00 | if you want evidence that it is about to happen, then ask senior executives at Shire why they are not to move too far from base over the next few days | inv | |
12/1/2006 08:50 | ...opened a short. | markth | |
12/1/2006 08:50 | I'm starting to..... | markth | |
12/1/2006 08:17 | now do you believe me. When i say something will happen, it is true | inv | |
11/1/2006 18:45 | If the US is anything to go by there is more to come tomorrow. | rfv | |
11/1/2006 17:00 | Yes I see that RNS. But some party accumulating a notifiable interest of 3% is quite different from a "bid at 975p" | markth |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions